Johnson & Johnson Stock Forecast
NYSE: JNJHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 11:59 AM ET
JNJ analyst consensus
Consensus (23 analysts)
buy
Avg. price target
$279.64+7.72%
- Strong buy 5
- Buy 11
- Hold 6
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 23 Wall Street analysts covering Johnson & Johnson (2026-10-07), 16 rate the stock a buy or strong buy, 6 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $279.64, with a high estimate of $320.00 and a low estimate of $190.00. The average target implies upside of 7.7% from the current price of $259.60.
The spread between the highest and lowest targets is 68.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for JNJ.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 5 | 22% |
| Buy | 11 | 48% |
| Hold | 6 | 26% |
| Sell | 1 | 4% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $190.00 | -26.81% |
| Average target | $279.64 | +7.72% |
| High target | $320.00 | +23.27% |